Nouveau Monde Graphite

Phase A — Understand the business

Company Overview

Nouveau Monde Graphite is a Québec-based, vertically-integrated natural-graphite developer building the West's first mine-to-active-anode-material ("AAM") supply chain outside China. It is a Canadian company, incorporated in Canada, HQ at Saint-Michel-des-Saints, Québec; dual-listed NYSE: NMG / TSX: NOU; fiscal year ends December 31; reports in Canadian dollars under IFRS; FX reference US$1.00 = C$1.3706 at 2025-12-31. Founder-CEO Eric Desaulniers (company founded 2012). Auditor PwC (PCAOB #271); the company is an emerging-growth company and is therefore exempt from SOX 404(b) external attestation of internal controls.

The business is two assets welded into one integrated project ("Phase-2"):

1. Matawinie Mine — a large open-pit natural flake-graphite mine (~106,000 tpa graphite concentrate), 150 km north of Montréal.
2. Bécancour Battery Material Plant (BMP) — a downstream plant that refines concentrate into coated spherical purified graphite (CSPG) active anode material for lithium-ion batteries. Full Phase-2 nameplate ~44,000 tpa AAM; being built in stages, with a First-Stage plant of ~13,000 tpa dedicated to Panasonic first.

There is also a Phase-1 legacy (a demonstration mine + demonstration plants at Bécancour — shaping, coating, purification, concentrator lines) used to qualify material with customers, and an earlier-stage Uatnan Mining Project (a separate, much larger graphite deposit, PEA-stage).

Contract structure — the key to the whole thing. Revenue is pre-sold under take-or-pay / fixed-benchmark offtakes covering >70–85% of planned Phase-2 AAM output:

• Government of Canada — 30,000 tpa concentrate-equivalent, 7-year, take-or-pay, priced on a North American fixed benchmark + annual inflation, with 50/50 upside-sharing on resale above the fixed price. This is the most important commercial fact in the file — a sovereign floor buyer.
• Panasonic Energy — binding multi-year offtake, 18,000 tpa AAM, initial 7-year term, formula-priced to prevailing market with a floor mechanism to satisfy project-finance ratios.
• Traxys North America — graphite concentrate offtake.
• GM — offtake + equity; GM is the single largest holder (~7.77%).

Customers: battery cell makers (Panasonic) and automakers (GM), plus the merchant/industrial graphite market (Traxys as trader), plus the Canadian government as strategic-reserve buyer. Suppliers: it is the upstream (owns the ore body); key external inputs are power (Hydro-Québec 120-kV line), reagents, and the EPC/contractor stack. Competitors: Chinese integrated anode majors (BTR, Shanshan, Putailai) on cost; ex-China developers Syrah, Novonix, Westwater, Posco/Mitsubishi JVs on the "friend-shored" niche.

Supply Chain

Map, upstream → NMG → end customer, with named stakeholders:

Upstream inputs → NMG:

• Ore body (Matawinie flake-graphite deposit) — NMG-owned, so no third-party feedstock dependency for concentrate (a genuine structural advantage vs. Novonix, which buys feedstock). Chokepoint risk is geological/permitting, not supply.
• Power — Hydro-Québec builds and operates the 120-kV line connecting Matawinie to the grid; carbon-free hydropower is the ESG selling point and a single-source schedule dependency — commissioning is gated on the line being live. Chokepoint.
• Reagents / purification chemistry — hydrofluoric-acid-free purification is NMG's claimed process edge; reagent suppliers are commodity.
• Brownfield building — a 143,000 m² existing building at Bécancour acquired to house the First-Stage plant, cutting greenfield construction cost.
• EPC / contractors — integrated project team + contractors mobilized on-site; key contracts covering >50% of project capex secured within budget as of the FID.

NMG (the two plants): Matawinie mine → concentrate → trucked ~150 km → Bécancour BMP → shaping → purification → coating → CSPG active anode material.

NMG → end customer:

• Concentrate → Government of Canada (strategic reserve), Traxys (merchant trading), and internal feed to Bécancour.
• AAM (CSPG) → Panasonic Energy (→ its North American gigafactories, incl. the Tesla/Panasonic supply chain) and GM (→ Ultium/its cell JVs).
• Financiers embedded in the chain: EDC + Canada Infrastructure Bank (senior debt), Eni / Canada Growth Fund / Investissement Québec / Mitsui / Pallinghurst / Panasonic (equity). Government sits on both the demand side (offtake) and the capital side (equity + debt) — this is a state-underwritten chain, not a market one.

Single-source / chokepoint summary: (1) Hydro-Québec powerline for commissioning; (2) customer qualification — Panasonic/GM must qualify each production batch, and AAM qualification is the industry's serial killer of timelines (Novonix's Panasonic qualification slipped mass production to H2 2027 ); (3) single ore body / single downstream site = no geographic redundancy. Names present — this lens passes.

Competitive Advantages (moats)

NMG's moat is not cost and not technology in the durable sense — it is geography + policy + a pre-built customer/capital syndicate. Ranked by durability:

1. Policy moat (strong but time-boxed). US Commerce's Feb-2026 final determination stacked duties on Chinese AAM to ~220% cumulative (66.68% CVD + 93.5% AD + 25% s.301 + 25% s.232 + 10% IEEPA). IRA 45X + FEOC rules reward North-American, non-FEOC anode. This is a tariff wall that makes a high-cost Québec plant economic — but it is a policy artifact, not a company asset, and it can be unwound faster than a mine can be built (see Lens 13). The single most important variable in the thesis.
2. Integration + traceability (moderate). Owning ore-to-anode gives a carbon-neutral, fully-traceable, FEOC-clean product — exactly what OEMs need for IRA credit qualification. Competitors who buy feedstock (Novonix) or only mine (Syrah upstream) can't offer the same single-throat traceability. Durable while OEMs value it; erodes if IRA sourcing rules loosen.
3. The syndicate as a moat (underrated). Panasonic + GM + Mitsui + Eni + two sovereign funds is a pre-committed demand-and-capital cartel that a new entrant cannot easily replicate — the offtakes and the >US$630M financing package are, in effect, a barrier to entry for the next would-be Western graphite developer.
4. Feedstock ownership (structural). Bargaining power over suppliers is high (it owns the mine). Bargaining power over customers is low-to-moderate — Panasonic/GM are giants, and the offtake pricing is formula/benchmark-linked with buyer-favorable qualification conditions precedent; NMG needs them more than they need NMG in the near term.

What it is not: no brand, no network effect, no switching-cost lock beyond qualification stickiness, no cost advantage vs. China at spot. The moat is a regulatory wall around a commodity, plus a hard-to-copy Rolodex.

Segments

our figures is empty — no segment revenue exists because the company is pre-commercial (n/a — pre-revenue). The economically meaningful "segments" are the product streams of the future asset, per the 2025 FS:

Geography is single-node: all production in Québec, all near-term sales into North America / Japanese-owned NA gigafactories. The "trend" that matters is stage progression, not mix: pre-revenue → First-Stage AAM (13kt, Panasonic) → full 44kt integrated → Uatnan optionality. Revenue turns on only when commercial production is reached (targeted end-2028).

---

Phase B — Measure performance

Earnings Result (latest print — Q1 2026)

There are no "earnings" in the operating sense — this is a cash-burn-to-milestone story. Read the print as a development-stage funding statement:

• Net loss Q1 2026: US$4.47M, vs. US$12.44M a year earlier; EPS −$0.02. The narrowing loss is mostly non-cash mark-to-market on derivative warrant/convertible liabilities, not operating improvement.
• Cash: ~US$74.5M (Q1 2026), net cash ~US$38.57M after debt/converts; ended FY2025 with ~C$74M cash.
• Balance-sheet flags: material derivative warrant liabilities and convertible notes (the Oct-2022 US$50M unsecured convert with Mitsui/IQ/Pallinghurst) create earnings noise and a dilution overhang. This is normal for a pre-FID junior but means reported net income is a poor guide to health — cash runway and financing progress are the real "print."
• The actual Q1–Q2 2026 "results" are corporate, not financial: (a) US$96.5M subscription-receipt bought deal at US$1.84 (April 16 2026); (b) the US$297M equity package (Eni US$70M + Canada Growth Fund + Investissement Québec + public); (c) US$335M EDC/CIB senior debt (US$290M term loan + US$45M overrun facility); (d) FID confirmed and Matawinie groundbreaking, May 19 2026. For a developer, these are the beats — and they are decisively positive.
• Market reaction: despite closing financing and reaching FID, the stock sits ~US$1.45–1.51 (June 2026) — ~93% below its Feb-2021 ATH of ~US$20.70. The market has not re-rated on de-risking; it is pricing execution + dilution + graphite-price risk, not celebrating the milestone.

Earnings Calls (sentiment trend)

transcripts/ is empty; sentiment is inferred from the cadence of press releases and quarterly updates, not from compiled call text (labeled accordingly). The arc of management messaging 2023 → 2026:

• 2023–2024: "roadmap to FID," offtake-hunting, repeated FID-timing language ("H2," "on track") against a slipping FID — classic junior-developer optimism with the date drifting. Recurring phrases: "fully integrated ore-to-anode," "carbon-neutral," "Western supply chain," "strategic partnerships."
• Late 2024 → 2025: tone shifts from promising to assembling — Canada Growth Fund + IQ US$50M (Dec 2024), the updated 2025 feasibility study (March 2025), and a pivot to phasing/sequencing the Bécancour plant (First-Stage 13kt first) to shrink the funding gap. This is a credibility-positive shift: management stopped promising the full US$1.33B build and re-scoped to something financeable.
• 2026: decisively execution-mode — "construction start," "groundbreaking," "key contracts >50% of capex secured," "FID confirmed." The word that appears: funded. The word that recedes: "toward FID."

Net: the sentiment trajectory is genuinely improving and, unusually for a junior, is now backed by cash and a shovel in the ground — but the multi-year FID slippage is a permanent mark against management's calendar credibility (Lens 9).

Comps

Peer set = ex-China graphite/anode developers (the only honest comparison — big diversified miners and Chinese majors are different animals). Every name here is pre-revenue or loss-making, so earnings multiples are n/a; the meaningful axes are market cap, cash, and stage. Provenance: market caps `` with date; do not read EV/EBITDA or P/E into a pre-revenue cohort — fabricating one would be malpractice.

Read: NMG is the largest-cap and most-de-risked of the Western graphite developers by virtue of reaching FID with financing closed — a real distinction, since Novonix's cap collapsed ~80% YTD and the whole cohort is starved of capital. But "largest of a group of sub-scale, cash-burning juniors" is a low bar. On an EV/resource or EV/planned-tonne basis the cohort would be more comparable, but those inputs aren't cleanly sourced here — n/a rather than a manufactured multiple. The tell in the table: the sector's equity values are falling even as the policy tailwind strengthens, because dilution and time-to-cash are winning the tug-of-war.

Stock-Price Catalysts (5-year pattern)

What has actually moved NMG >5%:

• Feb 2021 — ATH ~$20.70, the EV/battery-materials SPAC-era mania peak (right around the 10-for-1 consolidation and NYSE up-listing). Pure sentiment/liquidity, not fundamentals.
• 2021–2023 — secular grind down as the EV-materials bubble deflated, graphite prices weakened, and FID kept slipping. Each "toward FID / roadmap" update that lacked a hard financing commitment was a de-rating catalyst.
• Feb 2024 — Panasonic + GM binding offtakes + investments → the qualitative de-risking event; positive but did not durably re-rate the equity.
• Dec 2024 — Canada Growth Fund + IQ US$50M → incremental positive.
• March 2025 — updated feasibility study (NPV US$1,053M, IRR 17.5%) → mixed: validated economics but also revealed a US$1.33B integrated capex the market doubted could be funded without massive dilution.
• Feb 2026 — US ~220% tariffs on Chinese graphite finalized → the macro catalyst; supportive of the sector narrative but NMG did not spike (China simultaneously suspended its export controls to the US to Nov-2026, muddying the signal).
• April–May 2026 — US$96.5M receipts, US$297M equity, US$335M debt, FID + groundbreaking → the definitive de-risking cluster; yet the stock stayed ~$1.45.

Pattern the market reveals: NMG trades on (1) financing/dilution events and (2) the China-policy narrative far more than on project milestones. Each capital raise is dilutive and the stock treats "funded" as "diluted," not "de-risked." Graphite spot price and the durability of the tariff wall are the macro drivers. It is a policy-and-dilution stock, not a milestone stock — reaching FID barely moved it, which tells you the milestone was already priced and the overhang is elsewhere (share count + graphite price).

---

Phase C — Judge people & books

Management

• Eric Desaulniers — Founder, President & CEO (company founded 2012; CEO since inception). A founder-geologist who took a Québec flake-graphite deposit from claim to a fully-financed, government-backed, OEM-offtaken integrated project with a shovel in the ground — a genuine, rare accomplishment in junior mining, where 95% of stories die at "toward FID." That is the bull read on him.
• Skin in the game: thin. Desaulniers holds only 0.26% ($1.66M) directly. After a decade and relentless dilution, the founder's economic stake is small — alignment is more reputational/optional-value than equity-weight. Total comp ~C$1.67M (29.5% salary / 70.5% bonus+equity) — not egregious for a NYSE-listed developer.
• Capital-allocation history: mixed, trending better. The record is a decade of serial dilution (10-for-1 reverse splitReverse stock splitMerging several shares into one to lift the share price. It changes nothing about what the company is worth, and is usually done to keep a listing or to prepare a larger raise. in 2021 after the share count ballooned to 370.6M; repeated placements, a US$50M convert, US$297M equity in 2026) — shareholders who bought the 2021 peak are down ~93%. But the recent allocation is defensible: re-scoping the Bécancour plant to a financeable First-Stage, buying a brownfield to halve plant capex, and pulling in non-dilutive-adjacent sovereign/strategic capital and cheap EDC/CIB debt rather than pure equity. The 2024–2026 vintage of decisions is materially better than the 2019–2022 vintage.
• Board / ownership tell: the register is now government-and-strategic-controlled — Investissement Québec ~17%, Canada Growth Fund ~13%, GM ~7.77%, plus Eni (~11.5% post-raise, one board seat), Mitsui, Panasonic, Pallinghurst. Average board tenure just ~1.5 years — a heavily refreshed board reflecting the new strategic holders. This cuts both ways: strong sponsors de-risk financing, but a ~0.26% founder stake against a wall of sovereign/strategic capital means the equity is a ward of the state — retail is a passenger, not a principal.
• Archetype: persistent founder-operator, now effectively a manager of a public-private consortium. For this stage (build-out of a nationally-strategic asset) that is arguably the right archetype — but it implies the upside is shared with, and the agenda partly set by, governments and strategics, not float holders.

Forensic Red Flags

Acting as a forensic analyst on a pre-revenue, IFRS, emerging-growth filer:

• Revenue recognition: n/a — no revenue. The forensic risk migrates to capitalization vs. expensing — how much development, engineering, and pre-production cost is being capitalized to the asset vs. expensed. A pre-production developer capitalizes aggressively by design; the risk is a future impairment if project economics deteriorate (graphite price, capex overrun). Watch PP&E / intangible additions vs. the shrinking reported loss — the narrowing net loss (Q1 US$4.47M) is partly capitalization + non-cash mark-to-market, not thrift.
• Derivative liabilities / convertibles: material warrant-derivative and convertible-note balances drive non-cash P&L volatility and a dilution overhang. Not fraud — but reported EPS is noise; use cash-flow and share-count.
• SBC: 70.5% of CEO comp is bonus/equity — normal for the sector but dilutive; watch total SBC vs. cash G&A.
• Going-concern / liquidity: the structural red flag for any developer — does cash reach commissioning? At ~US$74.5M cash + US$335M debt facility + US$297M equity + take-or-pay offtakes, the near-term going-concern risk is materially reduced vs. 12 months ago, but a capex overrun or graphite-price collapse would reopen it (hence the US$45M overrun facility and US$122M P50 risk reserve baked into the FS).
• Controls: management asserts ICFR effective as of 2025-12-31, but as an EGC the company is exempt from SOX 404(b) auditor attestation — a lower assurance bar; worth flagging, not alarming.
• Reporting nuance: IFRS, CAD-reported, no US-GAAP reconciliation provided (permitted under MJDS) — US investors are comparing apples to a Canadian-standards orange; reserves stated under NI 43-101 / CIM, not SEC S-K 1300.

Regulatory findings (required):

• SEC Litigation Releases: None — no LR names NMG (EDGAR EFTS, LR, 2021-07-06 → 2026-07-06).
• AAERs: None.
• Non-SEC enforcement: web search ("Nouveau Monde Graphite" (FTC OR DOJ OR FDA OR CFPB OR consent decree OR settlement OR fine OR penalty)) surfaced no material enforcement action — the company appears in government-support contexts (Canada Major Projects Office, EDC/CIB financing), not enforcement.
• 10-K/40-F Item on legal proceedings: the FY2025 40-F is a MJDS shell; material litigation, if any, sits in the AIF (Ex-99.1, not on disk). Cover disclosures flag only ordinary forward-looking/mining risks, no pending material litigation surfaced.
• Conclusion: No material regulatory or legal findings — verified via SEC EDGAR EFTS (LR, AAER), web search, and the 40-F cover as of 2026-07-06. (Caveat: the AIF's full Legal Proceedings section was not on the shelf; a refresh should ingest Ex-99.1.)

---

Phase D — Project & stress-test

Forward Projection

No EPS forecast is appropriate — NMG will not generate meaningful net income until commercial production (targeted end-2028), so a three-fiscal-year EPS path from 2026 would be losses of indeterminate magnitude driven by capitalization policy and non-cash marks — modeling it precisely would be false precision. The honest projection is a project-NPV + runway-to-cash-flow frame, mirroring the clinical-stage rNPVrNPVWhat a drug might eventually be worth, multiplied by the odds it ever gets approved. A way of pricing a lottery ticket rather than a business. logic:

Anchor — 2025 Updated Feasibility Study (integrated Phase-2):

• After-tax NPV US$1,053M; after-tax IRR 17.5%; 25-year mine life; ~105,882 tpa concentrate + ~44,000 tpa AAM; P50 risk reserve US$122M.
• Capex — reconciled (surfacing the apparent conflict per provenance rules):
• Matawinie mine standalone: US$421M.
• Original full integrated (mine + full 44kt AAM plant): ~US$1.33B.
• Optimized phased figure ~US$634–645M — this is not a like-for-like reduction of the US$1.33B; it reflects sequencing to a First-Stage 13kt Bécancour plant + a 143,000 m² brownfield building rather than the full greenfield 44kt plant. So both numbers are "right" for different scopes; the funded near-term project is the ~US$630M phased one, not the US$1.33B full build.
• Financing to fund it: US$335M EDC/CIB debt + US$297M equity (Eni/CGF/IQ/public) + US$96.5M receipts + take-or-pay offtakes → FID reached, funded for the phased build.

Scenario frame (illustrative, ``):

• Base: First-Stage AAM (13kt, Panasonic) commissions ~2028; concentrate + Gov-Canada take-or-pay provides floor revenue; equity converges toward a fraction of the US$1.05B NPV as execution de-risks — but IRR of 17.5% is thin for the risk, so the equity is only cheap if you believe the tariff-supported price deck holds.
• Bull: full 44kt integrated build proceeds, tariff wall persists past 2026, AAM pricing firms, NMG becomes the default Western anode supplier → multi-bagger off a ~$500M cap toward the NPV.
• Bear: capex overrun beyond the US$45M facility + China détente collapses the ex-China premium → the 17.5% IRR goes negative, dilution resumes, impairment risk (see Lens 13).

Brier forecast: not logged — per --watchlist rules, no our model create in the sweep, and the natural binary here ("Matawinie reaches commercial production by 2028-12-31") belongs to a our position log pass with a committed probability, not this unattended dossier.

Bull vs Bear

Bull case. NMG is the first and most-de-risked integrated ore-to-anode developer in the West, now funded and building with a ~US$1.05B-NPV asset, ~85% of AAM output pre-sold to Panasonic + GM, a sovereign take-or-pay floor from the Government of Canada, and a capital stack underwritten by two governments, Eni, Mitsui, and cheap EDC/CIB debt. The policy backdrop is a ~220% tariff wall plus IRA 45X/FEOC that structurally favors exactly this product. It sits at a ~93%-off, ~US$500M cap — a levered call on the single clearest critical-minerals reshoring thesis, with the mine risk largely retired at FID. If the West is serious about de-Sinicizing batteries, NMG is a national champion the state cannot let fail.

Bear case (2–3 permanent-impairment risks).

1. The moat is a policy that can be repealed faster than the plant can scale. China already suspended its graphite export controls to the US through Nov-2026 and floods the market at prices NMG can't match; if the US tariff wall is negotiated down (trade détente, EV-demand politics), the entire economic rationale for a high-cost Québec anode evaporates and the 17.5% IRR goes negative. This is the thesis-killer.
2. Execution + capex overrun on a first-of-kind integrated build. No Western player has run mine-to-CSPG at scale; qualification is brutal (Novonix slipped to H2-2027); a build overrun beyond the US$45M facility forces more dilution into a ~$500M cap — the 2019–2022 dilution movie on repeat.
3. Thin economics + graphite oversupply. Even at plan the after-tax IRR is only 17.5% and Northeast-Asia graphite fell ~18% in 2025 on chronic oversupply — a commodity trough plus formula-linked offtake pricing could leave the project cash-flow-marginal, inviting an asset impairment.

Pre-mortem (18 months out, thesis broke). It's late 2027: China's export-control suspension lapsed but was replaced by a US–China trade deal that rolled back the anti-dumping/CVD stack; ex-China anode premiums compressed; Matawinie construction ran ~15% over budget; the First-Stage Bécancour plant is behind on Panasonic qualification; NMG did a fresh dilutive raise at a lower price to bridge to commissioning; the equity is sub-$1. The mine got built — but into a market that no longer paid the reshoring premium the model required.

Are multiples too high? No — the equity trades at a fraction of its own FS NPV; the risk is not that it's expensive but that the NPV itself is contingent on a policy price deck. Cheap-on-paper, binary-in-reality.

Contrarian view (what the market refuses to see). The market is treating NMG as "just another diluting junior" and ignoring that FID + a sovereign take-or-pay + a two-government cap table changes the survival distribution — this is one of the very few Western graphite names that structurally cannot be allowed to fail for national-security reasons, which caps the downside far more than the chart implies. The bear owns the price deck; the bull owns the balance sheet.

Devil's Advocate (short-seller)

Dismantling the bull case.

• Structural break: the way NMG makes money only exists because of a tariff differential. It is not a low-cost producer — it is a high-cost producer protected by a wall. Remove or lower the wall (a plausible outcome of any US–China trade normalization, or a change in US administration priorities) and the business model is underwater at spot, full stop.
• Revenue concentration: ~85% of AAM pre-sold to two buyers (Panasonic, GM), with conditions precedent and qualification hurdles in the offtakes. If GM's EVEnterprise valueWhat it would cost to buy the whole company: its market value plus its debt, minus the cash you would get with it. Often very different from market cap. volumes disappoint or Panasonic re-sources (Novonix is also qualifying with Panasonic), the offtakes could be renegotiated or delayed — the 40-F itself flags the ability to "terminate or renegotiate the current offtake agreements" for the Second-Stage plant. Concentration + optionality against NMG.
• Weaker moat than bulls think: traceability/carbon are nice-to-haves that OEMs pay for only while regulation forces them to; the underlying product is a commodity where China is structurally cheaper. No switching cost survives a big enough price gap.
• Most dangerous competitor bulls underestimate: not Syrah/Novonix — it's China itself, which can dump graphite below cost (as it did through 2025, −18% NE-Asia) to make every Western project uneconomic and starve the cohort of the pricing it needs. The suspension of export controls to Nov-2026 is a strategic weapon, not a concession.
• Worst capital-allocation history: a decade of dilution, a 10-for-1 reverse split, a ~93% drawdown, a 0.26% founder stake — the equity has been a value-destruction machine for float holders even as the project advanced. The people who made money were strategics buying preferred terms, not common holders.
• Assumptions that must hold for today's price: (1) the tariff wall persists ≥5 years; (2) construction lands near the ~US$630M phased budget; (3) qualification succeeds on schedule; (4) graphite price recovers or offtake floors hold; (5) no further large dilution. Break any one and the equity re-rates down.
• Growth disappoints 20–30%: if AAM demand/pricing comes in 20–30% light, the 17.5% IRR turns single-digit or negative and the FS NPV is not the right anchor — impairment and refinancing follow.
• Single scenario that permanently impairs: US–China trade détente that dismantles the anti-dumping/CVD stack on graphite. Plausibility: non-trivial — trade policy is volatile, EV affordability is politically salient, and China holds the leverage. That one policy reversal is the whole short.

Management Questions (ordered by information value)

1. If the US anti-dumping/CVD stack on Chinese graphite were cut in half, at what graphite price does the funded Phase-2 project still clear its cost of capital? (The thesis-defining sensitivity.)
2. What is the hard, contracted price floor in the Panasonic and Government-of-Canada offtakes — a fixed C$/t, or a formula with a floor — and what % of total Phase-2 revenue is genuinely floored vs. spot-exposed?
3. What are the remaining conditions precedent in the Panasonic offtake, and what specifically must be qualified before the First-Stage Bécancour plant can ship revenue-recognizable AAM?
4. What is the all-in sustaining cost per tonne of CSPG at steady state, and how does that compare to landed Chinese AAM after current tariffs vs. pre-tariff?
5. Post-FID, what is the total remaining funded-to-completion capex for the phased build, and how much contingency headroom exists above the US$45M overrun facility before another equity raise is required?
6. What is the cash runway to first commercial AAM revenue, and under what capex/schedule slip does a further financing become necessary?
7. The Hydro-Québec 120-kV line is a commissioning gate — what is its committed in-service date, and what is the mitigation if it slips relative to mine commissioning?
8. What is the realistic decision timeline and capex for the full 44kt integrated plant (vs. the 13kt First-Stage), and what demand signal triggers that FID?
9. How do you think about the China export-control suspension expiring Nov-2026 — is that a risk (renewed controls help you) or an opportunity, and how are you positioned for either outcome?
10. Given Eni's board seat and the two sovereign funds' stakes, who effectively controls strategic decisions, and how are minority common-shareholder interests protected in future dilution?
11. What is the Uatnan project's role — genuine Phase-3 optionality, or a resource for a future strategic/JV monetization?
12. What is the impairment trigger framework — at what sustained graphite price or IRR would the board recognize a write-down on the capitalized development spend?
13. How replaceable is NMG to Panasonic and GM if a qualified competitor (Novonix, Syrah) comes online first — what is your true switching-cost lock?
14. What does the customer qualification schedule look like quarter-by-quarter through commissioning, and what is the single most likely cause of a slip?
15. What is the long-term capital-return philosophy once at cash flow — deleverage the EDC/CIB debt, reinvest into full-scale/Uatnan, or return capital — and does the strategic syndicate's agenda align with that?

---